Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus-Reference-Cited by-同舟云学术

Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus

Published:2008-06 Issue:3 Volume:190 Page:238-245
ISSN:0940-9602
Container-title:Annals of Anatomy - Anatomischer Anzeiger
language:en
Short-container-title:Annals of Anatomy - Anatomischer Anzeiger

Author:

Cimpean Anca Maria,Raica Marius,Encica Svetlana,Cornea Remus,Bocan Viorica

Publisher

Elsevier BV

Subject

Developmental Biology,General Medicine,Anatomy

Reference35 articles.

1. Developing a new paradigm for thymus organogenesis;Blackburn;Nat. Immunol.,2004

2. Targeted agents for adjuvant therapy of colon cancer;De Gramont;Semin. Oncol.,2006

3. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis;Dvorak;Am. J. Pathol.,1995

4. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells;Fan;Oncogene,2005

5. Pituitary follicular cells secrete a novel heparin binding growth factor specific for vascular endothelial cells;Ferrara;Biochem. Biophys. Res. Commun.,1989

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies;International Journal of Molecular Sciences;2024-09-03

2. Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671);Annals of Oncology;2024-09

3. Patient with advanced aggressive B2 thymoma achieved positive outcomes post CAP-Endostar combination therapy;2024-07-03

4. Expression of vascular endothelial growth factor receptor in thymic epithelial tumors;Oncology Letters;2024-06-18

5. What Have We Learned from Molecularly Informed Clinical Trials on Thymomas and Thymic Carcinomas—Current Status and Future Directions?;Cancers;2024-01-18